Summary statistics of included papers
| Characteristic | No. of papers n = 13 | Author and year |
|---|---|---|
| Country | ||
| United States | 11 | Graham et al., 2020; (48) Graham et al., 2021; (49) Substance Abuse and Mental Health Services Administration, 2020; (50) Owens et al., 2020; (51) American Academy of Pediatrics, 2019; (52) Hadland and Chadi, 2020; (53) Gonzalvo et al., 2016; (55) Berg et al., 2021; (56) Sikka et al., 2021; (57) Sahr et al., 2020; (58) Silver et al., 2016 (59) |
| Canada | 2 | Chadi et al., 2021; (54) Health Canada, 2021 (60) |
| Target population (age in years)* | ||
| Adolescent (10–19) | 4 | Graham et al., 2020; (48) Owens et al., 2020; (51) American Academy of Pediatrics, 2019; (52) Chadi et al., 2021 (54) |
| Youth (15–24) | 11 | Graham et al., 2020; (48) Graham et al., 2021; (49) Substance Abuse and Mental Health Services Administration, 2020; (50) American Academy of Pediatrics, 2019; (52) Hadland and Chadi, 2020; (53) Chadi et al., 2021; (54) Berg et al., 2021; (56) Sikka et al., 2021; (57) Sahr et al., 2020; (58) Silver et al., 2016; (59) Health Canada, 2021 (60) |
| Adult (25–64) | 2 | Gonzalvo et al., 2016; (55) Sikka et al., 2021 (57) |
| Study design | ||
| RCT | 1 | Graham et al., 2021 (49) |
| Pretest–posttest experimental study | 1 | Graham et al., 2020 (48) |
| Guidance or recommendation | 7 | Substance Abuse and Mental Health Services Administration, 2020; (50) Owens et al., 2020; (51) American Academy of Pediatrics, 2019; (52) Hadland and Chadi, 2020; (53) Chadi et al., 2021; (54) Gonzalvo et al., 2016; (55) Berg et al., 2021 (56) |
| Case report or case series | 3 | Sikka et al., 2021; (57) Sahr et al., 2020; (58) Silver et al., 2016 (59) |
| Qualitative study | 1 | Health Canada, 2021 (60) |
| Type of intervention recommended | ||
| Behavioural | 10 | Graham et al., 2020; (48) Graham et al., 2021; (49) Substance Abuse and Mental Health Services Administration, 2020; (50) Hadland and Chadi, 2020; (53) Chadi et al., 2021; (54) Berg et al., 2021; (56) Sikka et al., 2021; (57) Sahr et al., 2020; (58) Silver et al., 2016; (59) Health Canada, 2021 (60) |
| NRT | 6 | American Academy of Pediatrics, 2019; (52) Hadland and Chadi, 2020; (53) Chadi et al., 2021; (54) Gonzalvo et al., 2016; (55) Sikka et al., 2021; (57) Silver et al., 2016 (59) |
| Non-NRT | 3 | Hadland and Chadi, 2020; (53) Chadi et al., 2021; (54) Gonzalvo et al., 2016 (55) |
| Based evidence on vaping cessation | ||
| Yes | 7 | Graham et al., 2020; (48) Graham et al., 2021; (49) Substance Abuse and Mental Health Services Administration, 2020; (50) Berg et al., 2021; (56) Sikka et al., 2021; (57) Sahr et al., 2020; (58) Silver et al., 2016 (59) |
| No | 6 | Owens et al., 2020; (51) American Academy of Pediatrics, 2019; (52) Hadland and Chadi, 2020; (53) Chadi et al., 2021; (54) Gonzalvo et al., 2016; (55) Health Canada, 2021 (60) |
| Based on critical appraisal scores | ||
| High quality (critical appraisal scores ≥ 70%) | 10 | Graham et al., 2021; (49) Substance Abuse and Mental Health Services Administration, 2020; (50) Owens et al., 2020; (51) American Academy of Pediatrics, 2019; (52) Hadland and Chadi, 2020; (53) Chadi et al., 2021; (54) Berg et al., 2021; (56) Sikka et al., 2021; (57) Sahr et al., 2020; (58) Health Canada, 2021 (60) |
| Moderate quality (critical appraisal scores 50%–70%) | 3 | Graham et al., 2020; (48) Gonzalvo et al., 2016; (55) Silver et al., 2016 (59) |
| Low quality (critical appraisal scores < 50%) | 0 | |
Note: NRT = nicotine replacement therapy, RCT = randomized controlled trial.
↵* Target population categories of adolescent and youth had overlaps with each other.